PL392476A1 - Związki pochodne dibenzo [b, f] azepiny oraz sposoby ich otrzymywania - Google Patents

Związki pochodne dibenzo [b, f] azepiny oraz sposoby ich otrzymywania

Info

Publication number
PL392476A1
PL392476A1 PL392476A PL39247601A PL392476A1 PL 392476 A1 PL392476 A1 PL 392476A1 PL 392476 A PL392476 A PL 392476A PL 39247601 A PL39247601 A PL 39247601A PL 392476 A1 PL392476 A1 PL 392476A1
Authority
PL
Poland
Prior art keywords
azepine
dibenzo
obtaining
methods
derivative compounds
Prior art date
Application number
PL392476A
Other languages
English (en)
Other versions
PL217225B1 (pl
Inventor
Peter Funfschilling
Daniel Kaufmann
Olivier Lohse
Ulrich Beutler
Werner Zaugg
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9885081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL392476(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL392476A1 publication Critical patent/PL392476A1/pl
Publication of PL217225B1 publication Critical patent/PL217225B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL392476A 2000-02-07 2001-02-07 Związki pochodne dibenzo[b, f]azepiny oraz sposoby ich otrzymywania PL217225B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0002740.9A GB0002740D0 (en) 2000-02-07 2000-02-07 Organic compounds

Publications (2)

Publication Number Publication Date
PL392476A1 true PL392476A1 (pl) 2010-11-22
PL217225B1 PL217225B1 (pl) 2014-06-30

Family

ID=9885081

Family Applications (2)

Application Number Title Priority Date Filing Date
PL356404A PL214039B1 (pl) 2000-02-07 2001-02-07 Sposób wytwarzania zwiazku pochodnego dibenzo[b,f]azepiny
PL392476A PL217225B1 (pl) 2000-02-07 2001-02-07 Związki pochodne dibenzo[b, f]azepiny oraz sposoby ich otrzymywania

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL356404A PL214039B1 (pl) 2000-02-07 2001-02-07 Sposób wytwarzania zwiazku pochodnego dibenzo[b,f]azepiny

Country Status (33)

Country Link
US (1) US7112673B2 (pl)
EP (2) EP1265868B1 (pl)
JP (1) JP4859322B2 (pl)
KR (5) KR100931753B1 (pl)
CN (2) CN1244563C (pl)
AR (2) AR029442A1 (pl)
AT (2) ATE505459T1 (pl)
AU (1) AU767724B2 (pl)
BR (1) BR0107922A (pl)
CA (3) CA2639210C (pl)
CO (1) CO5271705A1 (pl)
CY (1) CY1111567T1 (pl)
CZ (1) CZ301572B6 (pl)
DE (2) DE60138271D1 (pl)
DK (1) DK2067772T3 (pl)
ES (2) ES2324900T3 (pl)
GB (1) GB0002740D0 (pl)
HU (1) HU229420B1 (pl)
IL (3) IL150613A0 (pl)
MX (1) MXPA02007629A (pl)
MY (1) MY136474A (pl)
NO (1) NO324949B1 (pl)
NZ (1) NZ520329A (pl)
PE (1) PE20011078A1 (pl)
PL (2) PL214039B1 (pl)
PT (2) PT2067772E (pl)
RU (1) RU2303591C2 (pl)
SI (1) SI2067772T1 (pl)
SK (1) SK287217B6 (pl)
TR (1) TR200201655T2 (pl)
TW (1) TWI284638B (pl)
WO (1) WO2001056992A2 (pl)
ZA (1) ZA200206219B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
EP1302464A1 (en) * 2001-10-09 2003-04-16 Max India Limited Process for preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
ITMI20040452A1 (it) 2004-03-09 2004-06-09 Clariant Lsm Italia Spa Processo per la preparazione di oxcarbazepina
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
US20090082335A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched oxcarbazepine
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
IN2015DN02296A (pl) 2012-09-26 2015-08-21 Ranbaxy Lab Ltd
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US11465978B2 (en) 2013-09-11 2022-10-11 The Administrators Of The Tulane Educational Fund Anthranilic amides and the use thereof
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847374A (en) * 1987-01-27 1989-07-11 Ciba-Geigy Corporation Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas
DE4305502A1 (de) * 1993-02-23 1994-08-25 Basf Ag Ortho-substituierte 2-Methoxyiminophenylessigsäuremethylamide
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
IT1283594B1 (it) 1996-04-12 1998-04-22 Trifarma Srl Derivati della 5h-dibenz- (b,f)-azepin-5-carbossiammide, loro preparazione e uso come sostanze ad azione medicinale
ATE344791T1 (de) * 1997-07-01 2006-11-15 Warner Lambert Co 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
US6048856A (en) 1997-12-17 2000-04-11 Novo Nordisk A/S Heterocyclic compounds

Also Published As

Publication number Publication date
PT1265868E (pt) 2009-07-15
TWI284638B (en) 2007-08-01
CN1394204A (zh) 2003-01-29
DK2067772T3 (da) 2011-07-18
ZA200206219B (en) 2003-04-04
KR20090102882A (ko) 2009-09-30
CN1244563C (zh) 2006-03-08
AU767724B2 (en) 2003-11-20
KR100931753B1 (ko) 2009-12-14
GB0002740D0 (en) 2000-03-29
HK1052501A1 (en) 2003-09-19
CA2395601C (en) 2010-01-05
KR20100018069A (ko) 2010-02-16
HUP0300243A3 (en) 2005-07-28
NO324949B1 (no) 2008-01-14
SK287217B6 (sk) 2010-03-08
CY1111567T1 (el) 2015-10-07
EP2067772A2 (en) 2009-06-10
EP1265868A2 (en) 2002-12-18
AR029442A1 (es) 2003-06-25
BR0107922A (pt) 2002-10-22
CZ301572B6 (cs) 2010-04-21
HU229420B1 (en) 2013-12-30
NZ520329A (en) 2003-11-28
IL150613A (en) 2010-05-17
HUP0300243A2 (hu) 2003-06-28
AU4237301A (en) 2001-08-14
PT2067772E (pt) 2011-07-13
KR101216285B1 (ko) 2012-12-28
IL188183A (en) 2011-02-28
EP1265868B1 (en) 2009-04-08
KR20080003016A (ko) 2008-01-04
EP2067772B1 (en) 2011-04-13
IL150613A0 (en) 2003-02-12
KR20080103608A (ko) 2008-11-27
PL356404A1 (pl) 2004-06-28
NO20023575D0 (no) 2002-07-26
CZ20022676A3 (cs) 2002-11-13
DE60144456D1 (de) 2011-05-26
NO20023575L (no) 2002-07-26
US7112673B2 (en) 2006-09-26
US20030032800A1 (en) 2003-02-13
CA2639210A1 (en) 2001-08-09
AR079237A2 (es) 2012-01-04
MY136474A (en) 2008-10-31
PL217225B1 (pl) 2014-06-30
ATE427938T1 (de) 2009-04-15
KR100966209B1 (ko) 2010-06-25
MXPA02007629A (es) 2002-12-13
CA2724295A1 (en) 2001-08-09
ATE505459T1 (de) 2011-04-15
CO5271705A1 (es) 2003-04-30
JP2003521536A (ja) 2003-07-15
CA2724295C (en) 2011-07-26
RU2002123334A (ru) 2004-01-10
CA2639210C (en) 2011-05-03
SK11262002A3 (sk) 2003-02-04
CN100455572C (zh) 2009-01-28
PL214039B1 (pl) 2013-06-28
WO2001056992A2 (en) 2001-08-09
CN1721409A (zh) 2006-01-18
RU2303591C2 (ru) 2007-07-27
PE20011078A1 (es) 2001-11-16
KR20020071033A (ko) 2002-09-11
CA2395601A1 (en) 2001-08-09
EP2067772A3 (en) 2009-08-19
DE60138271D1 (de) 2009-05-20
ES2363490T3 (es) 2011-08-05
TR200201655T2 (tr) 2002-11-21
ES2324900T3 (es) 2009-08-19
WO2001056992A3 (en) 2002-01-24
JP4859322B2 (ja) 2012-01-25
SI2067772T1 (sl) 2011-08-31

Similar Documents

Publication Publication Date Title
AU2882801A (en) Azepine derivatives
GB2379379B (en) Composite bowl
IL155177A0 (en) Method for the preparation of grf-peg conjugate
HUP0300243A3 (en) Dibenzo [b,f]azepine derivatives and process for their preparation
HUP0400296A3 (en) Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
AU9224101A (en) Benzodiazepine derivative
AU2001292241A1 (en) Benzodiazepine derivative
PL346034A1 (en) Method of obtaining substituted banzoylcyanide aminohydrazones
PL347015A1 (en) Method of obtaining cyclopropenes
PL339832A1 (en) Method of obtaining aromatic compounds
AU2001259374A1 (en) Tetrahedron modem
PL347407A1 (en) Method of obtaining derivatives of 5,6,7,8-tetrahydronaphtalen-2-ole
HUP0101447A3 (en) Process for the preparation of 5h-dibenz[b,f]azepine of high purity
PL344723A1 (en) Method of obtaining benzene
TW444550U (en) Improved structure of inner closet
PL336552A1 (en) Method of obtaining osmotherapeutic mixtures of anhydrohexithioles
HUP0301648A3 (en) Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines
PL341634A1 (en) Method of obtaining derivatives of phenylsulphonylmethyltetrazole
TW360024U (en) Improved structure for seat of ring-type incense
AUPQ056699A0 (en) Further improved tubular section
PL340740A1 (en) Method of obtaining stable caprolactam
SI1301469T1 (sl) Priprava 4-tioalkilbromobenzenskih derivatov
PL333760A1 (en) Method of obtaining ethylbenzene
PL363457A1 (pl) Nowe karboksamidynowe pochodne dibenz[b,f]azepinyi ich sole oraz sposób ich otrzymywania
PL340617A1 (en) Derivatives of 2-acylpyridine